Peptide Capsules
5-Amino-1MQ 50mg (60 Capsules)
$255.00PRODUCT SHORT DESCRIPTION
5-Amino-1MQ 50mg capsules deliver a high-purity synthetic small molecule nicotinamide N-methyltransferase (NNMT) inhibitor configured for oral pharmacokinetic, cellular metabolism, and energy expenditure research. This 60-capsule configuration provides an exceptionally precise biochemical vehicle for investigating intracellular NAD+ amplification, SIRT1 gene activation, and adipocyte bioenergetics.
Longevity, Performance & Obesity Research (60 Capsules)
$300.00PRODUCT SHORT DESCRIPTION
The Longevity, Performance & Obesity Research platform delivers a highly stable cellular energy matrix of 60 capsules, each containing a precise synergistic blend of 5-Amino-1MQ (50mg), NMN (50mg), and JBSNF-000088 (5mg). This encapsulated configuration is engineered for advanced laboratory investigations into NNMT enzyme inhibition, somatotropic metabolic flux, and NAD+-dependent sirtuin activation pathways.
Methylene Blue (10mg x 60 Capsules = 600mg)
$35.00PRODUCT SHORT DESCRIPTION
The Methylene Blue research platform delivers a highly stable cellular energy matrix of 60 capsules, each containing 100mg of premium Methylene Blue (600mg total mass). This encapsulated configuration is engineered for advanced laboratory investigations into mitochondrial electron transport, redox-mediated signaling, and neuroenergetics.
Orforglipron (12mg x 90 Capsules = 1,080mg)
$415.00PRODUCT SHORT DESCRIPTION
The Orforglipron research platform delivers a highly stable, oral non-peptide matrix of 90 capsules, each containing 12mg of premium Orforglipron (1,080mg total mass). As a small-molecule, partial GLP-1 receptor agonist, this higher-strength encapsulated configuration is engineered for advanced laboratory investigations into high-dose metabolic flux, sustained glycemic control, and continuous incretin pathway signaling.
Orforglipron (6mg x 90 Capsules = 540mg)
$290.00PRODUCT SHORT DESCRIPTION
The Orforglipron research platform delivers a highly stable, oral non-peptide matrix of 90 capsules, each containing 6mg of premium Orforglipron (540mg total mass). As a small-molecule GLP-1 receptor agonist, this encapsulated configuration is engineered for advanced laboratory investigations into metabolic flux, glycemic regulation, and continuous incretin pathway signaling without the risk of enzymatic degradation.
Repair and Recovery (60 Capsules) (Stable BPC-157 Arginate, Thymosin Beta-4 Fragment)
$300.00PRODUCT SHORT DESCRIPTION
The Repair and Recovery research platform delivers a synergistic oral-delivery matrix of 60 capsules containing highly stable BPC-157 Arginate salt and Thymosin Beta-4 (TB-500) fragment. This dual-action configuration is engineered for advanced laboratory investigations into mucosal lining cytoprotection, cellular migration, and accelerated tissue repair cascades.
SLU-PP-332 (1000mcg x 30 Capsules = 30,000mcg)
$160.00PRODUCT SHORT DESCRIPTION
SLU-PP-332 (1000mcg x 30 Capsules) is a high-concentration Estrogen-Related Receptor (ERR) agonist engineered for advanced research into cellular energy pathways. This 30-capsule configuration enables precise modeling of mitochondrial biogenesis and oxidative capacity in controlled laboratory environments.
SLU-PP-332 (250mcg x 60 Capsules = 15,000mcg)
$110.00PRODUCT SHORT DESCRIPTION
SLU-PP-332 is a precision-engineered Estrogen-Related Receptor (ERR) agonist designed for advanced metabolic and mitochondrial research. This 60-capsule kit facilitates the study of oxidative capacity and energy expenditure within controlled laboratory environments.
SLU-PP-332 (250mcg x 60 Capsules = 15,000mcg) (Copy)
$110.00PRODUCT SHORT DESCRIPTION
SLU-PP-332 is a precision-engineered Estrogen-Related Receptor (ERR) agonist designed for advanced metabolic and mitochondrial research. This 60-capsule kit facilitates the study of oxidative capacity and energy expenditure within controlled laboratory environments.